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Abstract. This paper describes a novel method for improving classifi-
cation of support vector machines (SVM) with recursive feature selection
(SVM-RFE) when applied to cancer classification with gene expression
data. The method employs pairs of support vectors of a linear SVM-
RFE classifier for generating a sequence of new SVM classifiers, called
local support classifiers. This sequence is used in two Bayesian learning
techniques: as ensemble of classifiers in Optimal Bayes, and as attributes
in Naive Bayes. The resulting classifiers are applied to four publically
available gene expression datasets from leukemia, ovarian, lymphoma,
and colon cancer data, respectively. The results indicate that the pro-
posed approach improves significantly the predictive performance of the
baseline SVM classifier, its stability and robustness, with satisfactory re-
sults on all datasets. In particular, perfect classification is achieved on
the leukemia and ovarian cancer datasets.
1 Introduction
This paper deals with tumor classification with gene expression data. Microarray
technology provides a tool for estimating expression of thousands of genes simul-
taneously. To this end, DNA arrays are used, consisting of a large number of DNA
molecules spotted in a systematic order on a solid substrate. Depending on the
size of each DNA spot on the array, DNA arrays are called microarrays when the
diameter of DNA spot is less than 250 microns, and macroarrays when the diame-
ter is bigger than 300 microns. DNA microarrays contain thousands of individual
DNA sequences printed in a high density array on a glass microscope slide using
a robotic instrument. The relative abundance of these spotted DNA sequences in
the two DNA and RNA samples may be assessed by monitoring the differential
hybridization of the two samples to the sequences on the array. For mRNA sam-
ples, the two samples are reverse-transcribed into cDNA, labeled using different
fluorescent dyes mixed (red-fluorescent dye Cy5 and green-fluorescent dye Cy3).
After these samples are hybridized with the arrayed DNA probes, the slides are
imaged using scanner that makes fluorescence measurements for each dye. The
log ratio between the two intensities of each dye is used as the gene expression
data (cf. [11]) expression(gene) = log2(int(Cy5)/int(Cy3)), were int(Cy5) and
int(Cy3) are the intensities of the two fluorescent dyes.
Four main machine learning tasks are used to analyze DNA microarray data:
clustering, e.g. for identifying tumor subtypes, classification, e.g. for tumor diag-
nostic, feature selection for potential tumor biomarker identification, and gene
regulatory network modeling. This paper deals with classification.
Many machine learning techniques have been applied to classify gene ex-
pression data, including Fisher linear discriminat analysis [10], k-nearest neigh-
bour [18], decision tree, multi-layer perceptron [17, 25], support vector machine
(SVM) [6, 13, 15, 21], boosting and ensemble methods [14, 7, 23, 3, 9]. A recent
comparison of classification and feature selection algorithms applied to tumor
classification can be found in [7, 23].
This paper introduces a method that improves the predictive performance of
a linear SVM with Recursive Feature Elimination (SVM-RFE) [15] on four gene
expression datasets. The method is motivated by previous work on aggregration
of classifiers [4, 5], where it is shown that gains in accuracy can be obtained by
aggregrating classifiers built from perturbed versions of the train set, for instance
using bootstrapping. Application of aggregration of classifiers to microarray data
is described e.g. in [10, 7, 3, 9].
In this paper a novel approach is proposed, for generating a sequence of
classifiers from the support vectors of a baseline linear SVM-RFE classifier.
Each pair of support vectors of the same class are used to generate an element
of the sequence, called local support classifier (lsc). Such classifier is obtained by
training SVM-RFE on data consisting of the two selected support vectors and
all the support vectors of the other class.
The sequence of lsc’s provides an approximate description of the data distri-
bution by means of a set of linear decision functions, one for each region of the
input space in a small neighbourhoods of two support vectors having equal class
label.
We propose to use this sequence of classifiers in Bayesian learning (cf. [20]).
The first technique applies Naive Bayes to the transformed data, where an ex-
ample is mapped into the binary vector of its classification values. The resulting
classifier is called Naive Bayes Local Support Classifier (NB-LSC). The second
technique applies Optimal Bayes to the sequence of lsc’s classifiers. The resulting
classifier is called Optimal Bayes Local Support Classifier (OB-LSC).
The two classifiers are applied to four publically available datasets for cancer
classification with gene expression. The results show a significant improvement
in predictive performance of OB-LSC over the baseline linear SVM-RFE classi-
fier, and a gain in stability. In particular, on the leukemia and ovarian cancer
datasets perfect classification is obtained, and on the other datasets performance
comparable to the best published results we are aware of.
The rest of the paper is organized as follows. The next two sections describe
the baseline and new methods. Sections 4 contains a short description of the
data. Section 5 reports results of experiments and discuss them. Finally, the
paper ends with conclusive considerations on research issues to be tackled in
future work.
2 Support Vector Machines
This section describes in brief SVM-RFE, the local support classifier construction
procedure, and the integration of the resulting classifier sequence in Naive Bayes
and Optimal Bayes classification.
2.1 SVM
In linear SVM binary classification [24, 8] patterns of two classes are linearly
separated by means of a maximum margin hyperplane, that is, the hyperplane
that maximizes the sum of the distances between the hyperplane and its closest
points of each of the two classes (the margin). When the classes are not linearly
separable, a variant of SVM, called soft-margin SVM, is used. This SVM vari-
ant penalizes misclassification errors and employs a parameter (the soft-margin
constant C) to control the cost of misclassification.
Training a linear SVM classifier amounts to solving the following constrained
optimization problem:
minw,b,ξk
1
2
||w||2 + C
m∑
i=1
ξi s.t. w · xi + b ≥ 1− ξi
with one constraint for each training example xi. Usually the dual form of
the optimization problem is solved:
minαi
1
2
m∑
i=1
m∑
j=1
αiαjyiyjxi · xj −
m∑
i=1
αi
such that 0 ≤ αi ≤ C,
∑m
i=1 αiyi = 0. SVM requires O(m
2) storage and O(m3)
to solve.
The resulting decision function f(x) = w · x + b has weight vector w =∑m
k=1 αkykxk. Examples xi for which αi > 0 are called support vectors, since
they define uniquely the maximum margin hyperplane.
Maximizing the margin allows one to minimize bounds on generalization
error. Because the size of the margin does not depend on the data dimension,
SVM are robust with respect to data with high input dimension. However, SVM
are sensitive to the presence of (potential) outliers, (cf. [15] for an illustrative
example) due to the regularization term for penalizing misclassification (which
depends on the choice of C).
2.2 SVM-RFE
The weights wi provide information about feature relevance, where bigger weight
size implies higher feature relevance. In this paper feature xi is scored by means
of the absolute value of wi. Other scoring functions based on weight features are
possible, like, e.g., w2i , which is used in the original SVM-RFE algorithm [15].
SVM-RFE is an iterative algorithm. Each iteration consists of the following
two steps. First feature weights, obtained by training a linear SVM on the train-
ing set, are used in a scoring function for ranking features as described above.
Next, the feature with minimum rank is removed from the data. In this way, a
chain of feature subsets of decreasing size is obtained.
In the original SVM-RFE algorithm one feature is discarded at each iteration.
Other choices are suggested in [15], where at each iteration features with rank
lower than a user-given theshold are removed. In general, the threshold influences
the results of SVM-RFE [15]. In this paper we use a simple instance of SVM-
RFE where the user specifies the number of features to be selected, 70% of the
actual number of features are initially removed, and then 50% at each further
iteration. These values are chosen after cross-validation applied to the training
set.
3 Local Support Classifiers
We propose to describe the distribution of the two classes by means of a sequence
of classifiers, generated from pairs of support vectors ofSVM-RFE. Each of these
classifiers, called local support classifier (lsc), is obtained using data generated
from two support vectors of the same class, and all support vectors of the other
class. In this way, each classifier uses only a local region near the two selected
support vectors when separating the two classes. Each classifier generated from
two (distinct) support vectors of the same class provides an approximate de-
scription of the distribution of the other class given the two selected support
vectors.
Before describing the procedure for constructing lsc’s, some notation used
throughout the paper is introduced.
– D denotes the training set,
– c denotes the classifier obtained by training a linear SVM on D,
– Sp and Sn denote the set of positive and negative support vectors of c,
respectively,
– Pairp and Pairn denote the set of pairs of distinct elements of Sp and Sn,
respectively.
The following procedure, called LSC, takes as input one (s, s′) in Pairp and
outputs a linear SVM classifier Cs,s′ by means of the following two steps.
1. Let Xp = {s, s′}. Assign positive class label to these examples.
2. Let Cs,s′ be the classifier obtained by training a linear SVM on data Xp∪Sn.
An analogous procedure is applied to generate Cs,s′ from pairs (s, s
′) in
Pairn.
When applied to all pairs of support vectors in Pairp, Pairn, LSC produces
a sequence of lsc’s. Such sequence of classifiers induces a data transformation,
called seqD, which maps example x in the sequence seqD(x) of class values
Cs,s′(x), with (s, s
′) in Pairp ∪ Pairn.
The construction of the sequence oflsc’s requires computation that grows
quadratically with the number of support vectors. However, this is not a severe
problem, since the number of examples, hence of support vectors, is small for
this type of data. Furthermore, LSC is applied to each pair of support vectors
independently, hence can be executed in parallel.
3.1 Naive Bayes and Optimal Bayes Classification
Naive Bayes (NB) is based on the principle of assigning to a new example the
most probable target value, given the attribute values of the example. In order
to apply directly NB to the original gene expression data, gene values need to be
discretized, since NB assumes discrete-valued attributes. Examples transformed
using seqD contain binary attributes, hence discretization is not necessary.
Let x be a new example. Suppose seqD(x) = (x1, . . . , xN ).
First, the prior probabilities py of the two target values are estimated by
means of the frequency of positive and negative examples occurring in the train
set D, respectively. Next, for each attribute value xi, the probability P (xi | y)
of xi given target value y is estimated as the frequency with which xi occurs as
value of i-th attribute among the examples of D with class value y. Finally, the
classification of x is computed as the y that maximizes the product
py
N∏
i=1
P (xi | y).
The resulting classifier is denoted by NB-LSC.
Optimal Bayes (OB) classifier is based on the principle of maximizing the
probability that a new example is classified correctly, given the available data,
classifiers, and prior probabilities over the classifiers.
OB maps example x to the class that maximizes the weighted sum
∑
Cs,s′
ws,s′I(Cs,s′ (x) = y),
where ws,s′ is the accuracy of Cs,s′ over D, and I is the indicator function, which
returns 1 if the test contained in its argument is satisfied and 0 otherwise. The
resulting classifier is denoted by OB-LSC.
4 Datasets
There are several microarray datasets from published cancer gene expression
studies, including leukemia cancer dataset, colon cancer dataset, lymphoma
dataset, breast cancer dataset, NCI60 dataset, ovarian cancer, and prostate
dataset. Among them four datasets are used in this paper, available e.g. at
http://sdmc.lit.org.sg/GEDatasets/Datasets.html.The first and third dataset
contain samples from two variants of the same disease, the second and last
dataset consist of tumor and normal samples of the same tissue. Table 1 shows
input dimension and class sizes of the datasets. The following short description
of the datasets is partly based on [7].
Table 1. Datasets description
Name Tot Positive Negative Genes
Colon 62 22 40 2000
Leukemia 72 25 47 7129
Lymphoma 58 26 32 7129
Ovarian 54 30 24 1536
4.1 Leukemia
The Leukemia dataset consists of 72 samples: 25 samples of acute myeloid
leukemia (AML) and 47 samples of acute lymphoblastic leukemia (ALL). The
source of the gene expression measurements is taken from 63 bone marrow sam-
ples and 9 peripheral blood samples. Gene expression levels in these 72 samples
are measured using high density oligonucleotide microarrays [2]. Each sample
contains 7129 gene expression levels.
4.2 Colon
The Colon dataset consists of 62 samples of colon epithelial cells taken from
colon-cancer patients. Each sample contains 2000 gene expression levels. Al-
though the original data consists of 6000 gene expression levels, 4000 out of
6000 were removed based on the confidence in the measured expression levels.
40 of 62 samples are colon cancer samples and the remaining are normal samples.
Each sample is taken from tumors and normal healthy parts of the colons of the
same patients and measured using high density oligonucleotide arrays [1].
4.3 Lymphoma
B cell diffuse large cell lymphoma (B-DLCL) is a heterogeneous group of tumors,
based on significant variations in morphology, clinical presentation, and response
to treatment. Gene expression profiling has revealed two distinct tumor subtypes
of B-DLCL: germinal center B cell-like DLCL and activated B cell-like DLCL
[19]. Lymphoma dataset consists of 24 samples of germinal center B-like and 23
samples of activated B-like.
4.4 Ovarian
Ovarian tissue from 30 patients with cancer and 23 without cancer were analyzed
for mRNA expression using glass arrays spotted for 1536 gene clones. Attribute
i of patient j is the measure of the mRNA expression of the i-th gene in that
tissue sample, relative to control tissue, with a common control employed for all
experiments [22].
5 Numerical Experiments
The two classifiers NB-LSC and OB-LSC, described in Section 3.1, are applied
to the four gene expression datasets the baseline SVM-RFE algorithm. In all
experiments the same value of the SVM parameter C = 10 is used, while the
number of selected genes was set to 30 for the lymphoma dataset and 50 for all
other datasets. These values are chosen by means of cross-validation applied to
the training set.
Because of the small size of the datasets, Leave One Out Cross Validation
(LOOCV) is used to estimate the predictive performance of the algorithms [12].
Table 2. Results of LOOCV: average sensitivity, specificity and accuracy (with stan-
dard deviation between brackets).
Method Dataset Sensitivity Specificity Accuracy
SVM-RFE Colon 0.90 (0.3038) 1.00 (0.00) 0.9355 (0.2477)
NB-LSC 0.75 (0.4385) 1.00 (0.00) 0.8387 (0.3708)
OB-LSC 0.90 (0.3038) 1.00 (0.00) 0.9355 (0.2477)
SVM-RFE Leukemia 0.96 (0.20) 1.00 (0.00) 0.9861 (0.1179)
NB-LSC 1.00 (0.00) 1.00 (0.00) 1.00 (0.00)
OB-LSC 1.00 (0.00) 1.00 (0.00) 1.00 (0.00)
SVM-RFE Ovarian 0.7000 (0.4661) 0.9583 (0.2041) 0.8148 (0.3921)
NB-LSC 1.00 (0.00) 1.00 (0.00) 1.00 (0.00)
OB-LSC 1.00 (0.00) 1.00 (0.00) 1.00 (0.00)
SVM-RFE Lymphoma 0.6923 (0.4707) 0.6562 (0.4826) 0.6724 ( 0.4734)
NB-LSC 1.00 (0.00) 0.6562 (0.4826) 0.8103 (0.3955)
OB-LSC 1.00 (0.00) 0.8750 (0.3360) 0.9310 (0.2556)
Table 2 reports results of LOOCV. They indicate a statistically significant
improvement of OB-LSC over the baseline SVM-RFE classifier, and a gain in sta-
bility, indicated by lower standard deviation values. In particular, on the ovarian
and leukemia datasets both NB-LSC and OB-LSC achieve perfect classification.
Moreover, while the performance of SVM on the Lymphoma dataset is rather
scare (possibly due to the fact that we did not scale the data), OB-LSC obtains
results competitive to the best results known (see Table 3).
Table 3. Comparison of results with best average accuracy reported in previous papers
on tumor classification. The type of classifiers considered in the paper are given between
brackets. An entry ’-’ means that the corresponding dataset has not been considered.
Colon Leukemia Lymphoma Ovarian
Furey et al (SVM) 0.90 0.94 - -
Li et al 00 (Logistic regression) - 0. 94 - -
Li et al 01 (KNN) 0.94 - 0.94 -
Ben-Dor et al (Quadratic SVM, 1NN, AdaBoost) 0.81 0.96 - -
Dudoit et al (1NN, LDA, BoostCART) - 0.95 0.95 -
Nguyen et al (Logistic discriminant, QDA) 0.94 0.96 0.98 -
Cho et al ( Ensemble SVM, KNN) 0.94 0.97 0.96 -
Liu et al 04 (Ensemble NN) 0.91 - - -
Dettling et al 03 (Boosting) 0.85 - - -
OB-LSC 0.94 1.00 0.93 1.00
Table 3 reports results of OB-LSC and the best result among those contained
nine papers on tumor classification and feature selection using different machine
learning methods [7]. Note that results reported in this table have been obtained
using different cross-validation methods, mainly by repeated random partitioning
the data into train and test set using 70 and 30 % of the data, respectively.
Because the resulting estimate of predictive performance may be more biased
than the one of LOOCV [12], those results give only an indication for comparing
the methods. Only the results on the colon dataset from Liu et al 04 and Dettling
et al 03 [9, 3] are obtained using LOOCV. The methods proposed in these latter
papers use boosting and bagging, respectively. The results they obtain seem
comparable to OB-LSC.
The results indicate that OB-LSC is competitive with most recent classifica-
tion techniques for this task, including non-linear methods.
6 Conclusion
This paper introduced an approach that improves predictive performance and
stability of linear SVM for tumor classification with gene expression data on four
gene expression datasets.
We conclude with two considerations on research issues still to be addressed.
Our approach is at this stage still an heuristic, and needs further experimental
and theoretical analysis. In particular, we intend to analyze how performance is
related to the number of support vectors chosen to generate lsc’s. Moreover, we
intend to investigate the use of this approach for feature selection, for instance
whether the generated lsc’s can be used for ensemble feature ranking [16].
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